
Midazolam evidence for neonatal seizures remains limited and heterogeneous
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
A systematic review found that midazolam produced an electro-clinical response in about two-thirds of 146 treated neonates, but the evidence was heterogeneous and insufficient to define which infants are most likely to benefit.
What NurseJet pulled from the source
Across 11 studies, 101 of 146 neonates had an electro-clinical response and 61 of 146 achieved seizure cessation. An exploratory complete-case analysis suggested a higher response probability with greater gestational age, but the authors described this finding as hypothesis-generating.
Why this matters for nurses
Neonatal seizure treatment requires medication-specific monitoring and electrographic assessment. This review supports careful surveillance when midazolam is used for refractory seizures without establishing it as a preferred universal regimen.
Bedside takeaway
Treat midazolam as a monitored add-on option for refractory neonatal seizures, not a one-size-fits-all regimen.
Key takeaways
- Electro-clinical response was reported in 69.2% of treated neonates, while seizure cessation was reported in 41.8%.
- Hypotension was the most frequently reported adverse event; respiratory depression, sedation-related effects, and transient EEG or aEEG suppression were reported less often.
- Variation in study design, monitoring, outcome definitions, and individual-level data limits confidence in the pooled observations.
Practice implications
- When midazolam is ordered for refractory neonatal seizures, follow the local seizure protocol and provider orders, maintain prescribed EEG or aEEG and cardiorespiratory monitoring, and promptly escalate hypotension, respiratory depression, excessive sedation, or persistent electrographic seizures.
Limitations & cautions
- Abstract-only summary. The 11 included studies were heterogeneous, individual-level data were incomplete, and the gestational-age analysis was exploratory rather than confirmatory.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
European journal of pediatrics (PubMed)
European journal of pediatrics (PubMed). Electro-clinical efficacy and safety of midazolam in neonatal seizures: a systematic review with individual level exploratory analysis of gestational age-related treatment response.
https://pubmed.ncbi.nlm.nih.gov/42736513/
Professional education only


